We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Worthington Biochemical Introduces AOF Collagenase/Neutral Protease Blends
Product News

Worthington Biochemical Introduces AOF Collagenase/Neutral Protease Blends

Worthington Biochemical Introduces AOF Collagenase/Neutral Protease Blends
Product News

Worthington Biochemical Introduces AOF Collagenase/Neutral Protease Blends


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Worthington Biochemical Introduces AOF Collagenase/Neutral Protease Blends"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Animal Origin Free (AOF) STEMxyme® collagenase/neutral protease (Dispase®) Blends 1 and 2, produced by Worthington Biochemical Corporation, are now available for primary and stem cell isolation, regenerative medicine, biopharmaceutical and cell bioprocessing applications.

These new, specialized combinations of AOF Clostridium histolyticum collagenase and AOF Bacillus polymyxa neutral protease (Dispase®) offer a minimum of 250 CLS units and 1,000 or 2,000 caseinase units per mg dry weight, respectively.

Produced at Worthington's ISO9001 Certified site, the blends are valuable in applications in which the potential for introduction of animal derived pathogens must be prevented and are available in research-scale to bulk-bioprocessing quantities.

Advertisement